Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Panizo

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Haematologica|March 24, 2022
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL studyAlejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, et al.
Science Advances|January 19, 2022
Preneoplastic somatic mutations including <i>MYD88</i><sup>L265P</sup> in lymphoplasmacytic lymphomaSara Rodriguez, Jon Celay, Ibai Goicoechea, et al.
Blood Advances|January 13, 2026
Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC StudyMarta Peña, Giulia Losi, Víctor Navarro, et al.
The Journal of Pathology|February 22, 2018
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemiaMaria J García-Barchino, Maria E Sarasquete, Carlos Panizo, et al.
Annals of Hematology|February 21, 2020
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO groupMariana Bastos-Oreiro, Ana Muntañola, Carlos Panizo, et al.
Nature Medicine|March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaMarta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
Nature Communications|June 15, 2016
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamicsEloy F Robles, Maria Mena-Varas, Laura Barrio, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Haematologica|March 24, 2022
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL studyAlejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, et al.
Science Advances|January 19, 2022
Preneoplastic somatic mutations including <i>MYD88</i><sup>L265P</sup> in lymphoplasmacytic lymphomaSara Rodriguez, Jon Celay, Ibai Goicoechea, et al.
Blood Advances|January 13, 2026
Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC StudyMarta Peña, Giulia Losi, Víctor Navarro, et al.
The Journal of Pathology|February 22, 2018
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemiaMaria J García-Barchino, Maria E Sarasquete, Carlos Panizo, et al.
Annals of Hematology|February 21, 2020
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO groupMariana Bastos-Oreiro, Ana Muntañola, Carlos Panizo, et al.
Nature Medicine|March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaMarta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
Nature Communications|June 15, 2016
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamicsEloy F Robles, Maria Mena-Varas, Laura Barrio, et al.
Pageof 6